Literature DB >> 1952826

Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group.

W A Rocca1, A Hofman, C Brayne, M M Breteler, M Clarke, J R Copeland, J F Dartigues, K Engedal, O Hagnell, T J Heeren.   

Abstract

We reanalyzed and compared current prevalence estimates of Alzheimer's disease in Europe. Studies characterized as follows qualified for comparison: dementia defined by the Diagnostic and Statistical Manual for Mental Disorders, 3rd edition, or equivalent criteria; Alzheimer's disease diagnosed by the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association or equivalent criteria; case-finding through direct individual examination; appropriate sample size; and inclusion of institutionalized persons. Of the 23 European surveys of dementia considered, six fulfilled the inclusion criteria. When age and sex were considered, there were no major geographic differences in the prevalence of Alzheimer's disease across Europe. Overall European prevalence (per 100 population) for the age groups 30 to 59, 60 to 69, 70 to 79, and 80 to 89 years was, respectively, 0.02, 0.3, 3.2, and 10.8. Prevalence increased exponentially with advancing age and, in some populations, was consistently higher in women. Prevalence remained stable over 15 years in one study.

Entities:  

Mesh:

Year:  1991        PMID: 1952826     DOI: 10.1002/ana.410300310

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  68 in total

Review 1.  The epidemic of Alzheimer's disease. How can we manage the costs?

Authors:  N Johnson; T Davis; N Bosanquet
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

Review 2.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

3.  A genome-wide linkage analysis of dementia in the Amish.

Authors:  Daniel W Hahs; Jacob L McCauley; Amy E Crunk; Lynne L McFarland; Perry C Gaskell; Lan Jiang; Susan H Slifer; Jeffery M Vance; William K Scott; Kathleen A Welsh-Bohmer; Stephanie R Johnson; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

Review 4.  The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

Authors:  Anna M Barron; Giuseppe Verdile; Ralph N Martins
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 5.  Cognitive aging and Alzheimer's disease.

Authors:  R Vandenberghe; J Tournoy
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 6.  Alzheimer's disease: epidemiology, genetics, and beyond.

Authors:  Xiao-Ping Wang; Hong-Liu Ding
Journal:  Neurosci Bull       Date:  2008-04       Impact factor: 5.203

7.  Deaths attributable to Alzheimer's disease in the United States.

Authors:  D C Ewbank
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

Review 8.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

9.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.

Authors:  H Payami; S Zareparsi; K R Montee; G J Sexton; J A Kaye; T D Bird; C E Yu; E M Wijsman; L L Heston; M Litt; G D Schellenberg
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

10.  Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer's Patients.

Authors:  Mahdi Zamani; Masomeh Mohammadi; Hamid Zamani; Alireza Tavasoli
Journal:  Mol Neurobiol       Date:  2015-08-21       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.